ArticleBMC cancer2025

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial.

Ke Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.